“AI agents make powerful scientific capabilities accessible to all drug researchers, not just those with computational expertise,” said Rajiv Chopra, vice president of AWS Healthcare AI and Life Sciences. “These AI systems can help scientists design drug molecules, coordinate testing, learn from the results, and become smarter with each experiment. This combination of cutting-edge AI and the robust, secure infrastructure that AWS has built for regulated industries allows scientists to accelerate antibody discovery in a way that was not possible before.
Add A Comment